About Conference
It is our great pleasure and honor to extend to you a warm welcome to attend the “3rd International Conference on Retroviruses and Novel Drugs”to be held from July 27-28, 2017 vancouver, Canada. The theme of this year conference is “Novel therapy and innovations for treatment of retroviruses”.
The theme of this year conference is “Novel therapy and innovations for treatment of retroviruses”. brings together renowned experts from the international scientific community to provide a premier inter-multi-trans-disciplinary to exchange their latest results related to retroviral research, infections, rational drug designs and novel therapies.
Retroviruses-2017 is anticipating participation from renowned speakers including researchers, basic scientists and clinicians, and many from leading universities, companies and virology research institutions, hospitals sharing their novel researches in the arena of Retroviruses and Novel Drugs. This virology conference paves a way to gather visionaries through the research talks, plenary lectures, symposia, workshops, invited sessions and oral and poster sessions of unsolicited contributions.
Conference series LLC Organises 1000+Conferences Every Year across USA, Europe & Asia with support from 1200 more scientific societies and Publishes 700+Open access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Retrovirology is an open access, online journal that publishes stringently peer-reviewed, high-impact articles on basic retrovirus research. Retroviruses are pleiotropically found in animals. Well-described examples include avian, murine and primate retroviruses. Two human retroviruses are especially important pathogens. These are the human immunodeficiency virus, HIV, and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-I is the etiological agent for adult T-cell leukemia. Retrovirology intends to cover these areas of human and animal retrovirus research. More than 1.2 million people in the US are living with HIV, and 1 in 8 of them don’t know it.Over the last decade, the annual number of new HIV diagnoses declined 19%.Gay and bisexual men, particularly young African American gay and bisexual men, are most affected. African Americans continue to experience the greatest burden of HIV compared to other races and ethnicities. From 2005 to 2014: Diagnoses among all women declined 40%, and among African American women, diagnoses declined 42%. Among all heterosexuals, diagnoses declined 35%, and among people who inject drugs, diagnoses declined 63%
Retrovirology is an open access, online journal that publishes stringently peer-reviewed, high-impact articles on basic retrovirus research. Retroviruses are pleiotropically found in animals. Well-described examples include avian, murine and primate retroviruses. Two human retroviruses are especially important pathogens. These are the human immunodeficiency virus, HIV, and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-I is the etiological agent for adult T-cell leukemia. Retrovirology intends to cover these areas of human and animal retrovirus research. More than 1.2 million people in the US are living with HIV, and 1 in 8 of them don’t know it.Over the last decade, the annual number of new HIV diagnoses declined 19%.Gay and bisexual men, particularly young African American gay and bisexual men, are most affected. African Americans continue to experience the greatest burden of HIV compared to other races and ethnicities. From 2005 to 2014: Diagnoses among all women declined 40%, and among African American women, diagnoses declined 42%. Among all heterosexuals, diagnoses declined 35%, and among people who inject drugs, diagnoses declined 63%
Conference Highlights
- Retrovirus diseases
- Retroviral treatment
- Recent advances in retroviral therapy
- Retroviral delivery system
- Retroviral syndrome
- Human Endogenous and Exogenous Retroviruses
- Retroviruses and osteoporosis
- Antiretroviral therapy drugs
- Retroviral gene transduction
- Retrovirus and cancer
- Reteroviral Co-Infections
- Theraputic approches of novel drugs
Special Issues
- All accepted abstracts will be published in respective OMICS International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: http://retrovirus.conferenceseries.com/
No comments:
Post a Comment